Disruptive Pharma (5LH0) Stock Overview

Disruptive Pharma Holding Ab (Publ) operates as a pharmaceutical technology company that develops and commercializes patented platform technology for the formulation and development of pharmaceutical products. More details

5LH0 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€6M)

Has not reported any financial data

5LH0 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW477,830 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

477,830 investors already sharing narratives

View all narratives

Disruptive Pharma AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Disruptive Pharma
Historical stock prices
Current Share Price	SEK 0.10
52 Week High	SEK 2.27
52 Week Low	SEK 0.0001
Beta	0
1 Month Change	-5.42%
3 Month Change	1,000.00%
1 Year Change	-94.82%
3 Year Change	-74.70%
5 Year Change	-98.33%
Change since IPO	-98.43%

Recent updates

Shareholder Returns

	5LH0	DE Biotechs	DE Market
7D	-16.5%	-4.5%	2.2%
1Y	-94.8%	4.4%	3.5%

Return vs Industry: 5LH0 underperformed the German Biotechs industry which returned 4.4% over the past year.

Return vs Market: 5LH0 underperformed the German Market which returned 3.5% over the past year.

Price Volatility

Is 5LH0's price volatile compared to industry and market?
5LH0 volatility
5LH0 Average Weekly Movement	2,522.9%
Biotechs Industry Average Movement	6.8%
Market Average Movement	5.3%
10% most volatile stocks in DE Market	12.8%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: 5LH0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 5LH0's weekly volatility has increased from 1514% to 2523% over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Peter Åsberg	www.disruptivepharma.com

Disruptive Pharma AB (publ) Fundamentals Summary

How do Disruptive Pharma's earnings and revenue compare to its market cap?
5LH0 fundamental statistics
Market cap	€5.64m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 5LH0 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
5LH0 income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 5LH0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/09 09:06
End of Day Share Price	2026/08/07 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Disruptive Pharma AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Disruptive Pharma AB (publ)DB:5LH0 Stock Report